NCT00682786View on ClinicalTrials.gov

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

December 31, 2008

Study Completion Date

August 31, 2010

Conditions
Rectal Carcinoma
Interventions
DRUG

5FU

RADIATION

Radiation

PROCEDURE

Surgery of resectable lesions

DRUG

Irinotecan

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00682786 - Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | Biotech Hunter | Biotech Hunter